Pacira BioSciences' Shares Outstanding (Diluted Average) fell 116.71% to $45.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.7 million, marking a year-over-year decrease of 116.71%. This contributed to the annual value of $46.2 million for FY2024, which is 1103.14% down from last year.
Per Pacira BioSciences' latest filing, its Shares Outstanding (Diluted Average) stood at $45.7 million for Q3 2025, which was down 116.71% from $45.9 million recorded in Q2 2025.
Pacira BioSciences' Shares Outstanding (Diluted Average)'s 5-year high stood at $52.5 million during Q2 2022, with a 5-year trough of $45.6 million in Q4 2021.
Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $46.4 million (2022), whereas its average is $48.3 million.
Per our database at Business Quant, Pacira BioSciences' Shares Outstanding (Diluted Average) surged by 1463.33% in 2022 and then plummeted by 1113.57% in 2024.
Pacira BioSciences' Shares Outstanding (Diluted Average) (Quarter) stood at $45.6 million in 2021, then grew by 1.99% to $46.5 million in 2022, then grew by 11.69% to $52.0 million in 2023, then decreased by 11.03% to $46.2 million in 2024, then dropped by 1.12% to $45.7 million in 2025.
Its Shares Outstanding (Diluted Average) was $45.7 million in Q3 2025, compared to $45.9 million in Q2 2025 and $46.5 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value